$337 Million is the total value of ORACLE INVESTMENT MANAGEMENT INC's 19 reported holdings in Q1 2020. The portfolio turnover from Q4 2019 to Q1 2020 was 35.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
QDEL | Buy | QUIDEL CORP | $176,643,000 | +34.0% | 1,805,983 | +2.8% | 52.48% | +112.1% |
BHVN | Sell | BIOHAVEN PHARMACTL HLDG CO L | $63,661,000 | -39.2% | 1,870,743 | -2.7% | 18.92% | -3.8% |
AXDX | Sell | ACCELERATE DIAGNOSTICS INC | $34,172,000 | -52.0% | 4,102,287 | -2.6% | 10.15% | -24.0% |
AGEN | Buy | AGENUS INC | $13,134,000 | +16.4% | 5,360,867 | +93.4% | 3.90% | +84.2% |
SLNO | SOLENO THERAPEUTICS INC | $9,212,000 | -19.1% | 3,870,627 | 0.0% | 2.74% | +28.1% | |
VRML | VERMILLION INC | $8,179,000 | +2.8% | 9,825,289 | 0.0% | 2.43% | +62.7% | |
AMRN | Sell | AMARIN CORP PLCspons adr new | $7,343,000 | -93.4% | 1,835,639 | -64.9% | 2.18% | -89.6% |
OPK | Buy | OPKO HEALTH INC | $5,994,000 | -6.8% | 4,473,076 | +2.3% | 1.78% | +47.6% |
QDEL | Sell | QUIDEL CORPcall | $3,877,000 | +24.6% | 157,400 | -36.5% | 1.15% | +97.3% |
PACB | Buy | PACIFIC BIOSCIENCES CALIF IN | $3,734,000 | -34.6% | 1,220,359 | +9.9% | 1.11% | +3.5% |
ATRS | Buy | ANTARES PHARMA INC | $2,896,000 | -10.5% | 1,227,114 | +78.3% | 0.86% | +41.7% |
MOTS | MOTUS GI HLDGS INC | $2,565,000 | -70.6% | 3,806,666 | 0.0% | 0.76% | -53.5% | |
BIOL | BIOLASE INC | $1,940,000 | -32.1% | 5,173,250 | 0.0% | 0.58% | +7.3% | |
BIIB | BIOGEN INC | $1,540,000 | +6.6% | 4,868 | 0.0% | 0.46% | +69.0% | |
CFRX | New | CONTRAFECT CORP | $742,000 | – | 128,845 | +100.0% | 0.22% | – |
YMAB | New | Y-MABS THERAPEUTICS INC | $658,000 | – | 25,212 | +100.0% | 0.20% | – |
BHVN | New | BIOHAVEN PHARMACTL HLDG CO Lcall | $218,000 | – | 100,000 | +100.0% | 0.06% | – |
AXDX | Sell | ACCELERATE DIAGNOSTICS INCcall | $55,000 | -96.3% | 388,400 | -19.7% | 0.02% | -94.3% |
AMRN | Sell | AMARIN CORP PLCcall | $2,000 | -100.0% | 351,000 | -82.1% | 0.00% | -99.9% |
DB | Exit | DEUTSCHE BANK AGnamen akt | $0 | – | -25,000 | -100.0% | -0.04% | – |
CFRX | Exit | CONTRAFECT CORP | $0 | – | -1,502,766 | -100.0% | -0.18% | – |
ABC | Exit | AMERISOURCEBERGEN CORP | $0 | – | -25,000 | -100.0% | -0.40% | – |
DERM | Exit | DERMIRA INC | $0 | – | -2,528,311 | -100.0% | -7.20% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-05-15
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
OPKO HEALTH INC | 42 | Q3 2023 | 10.6% |
PACIFIC BIOSCIENCES CALIF IN | 42 | Q3 2023 | 22.6% |
BIOGEN INC | 42 | Q3 2023 | 0.6% |
QUIDEL CORP | 36 | Q1 2022 | 52.5% |
AMARIN CORP PLC | 31 | Q3 2021 | 23.1% |
VERMILLION INC | 28 | Q1 2020 | 3.8% |
AGENUS INC | 25 | Q3 2023 | 9.8% |
TESARO INC | 23 | Q4 2018 | 27.8% |
ACCELERATE DIAGNOSTICS INC | 23 | Q2 2023 | 23.0% |
MAZOR ROBOTICS LTD | 20 | Q1 2018 | 18.0% |
View ORACLE INVESTMENT MANAGEMENT INC's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-14 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-15 |
13F-HR | 2022-05-16 |
13F-HR | 2022-02-14 |
13F-HR | 2021-11-15 |
View ORACLE INVESTMENT MANAGEMENT INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.